Mortality associated with primary hyperparathyroidism

被引:29
作者
Clifton-Bligh, P. B. [1 ,2 ]
Nery, M. L. [1 ]
Supramaniam, R. [3 ]
Reeve, T. S. [2 ,4 ]
Delbridge, L. [2 ,4 ]
Stiel, J. N. [1 ]
McElduff, A. [1 ,2 ]
Wilmshurst, E. G. [1 ]
Robinson, B. G. [1 ,2 ]
Fulcher, G. R. [1 ,2 ]
Learoyd, D. [1 ,2 ]
Posen, S. [1 ,2 ]
机构
[1] Royal N Shore Hosp, Dept Endocrinol, St Leonards, NSW 2065, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] NSW Canc Council, Sydney, NSW, Australia
[4] Royal N Shore Hosp, Dept Endocrine Surg, St Leonards, NSW 2065, Australia
关键词
Hyperparathyroidism; Mortality; SERUM PARATHYROID-HORMONE; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; FOLLOW-UP; VITAMIN-D; CARDIOVASCULAR MORTALITY; ESSENTIAL-HYPERTENSION; INSULIN SENSITIVITY; 25-HYDROXYVITAMIN D; RENAL-FUNCTION;
D O I
10.1016/j.bone.2014.12.067
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
561 patients with primary hyperparathyroidism were followed between 1961 and 1994. Relative survival was compared to that of the Australian population studied during the same time interval. Mortality was significantly greater in the hyperparathyroid population (P < 0.001). Mortality was not greater in the patients with serum calcium levels >3.00 mmol/L compared to those with a serum calcium levels <3.00 mmol/L. 113 patients did not have parathyroid surgery. Their relative survival was not significantly different from those who had surgery but their mean serum calcium and parathyroid hormone (PTH) levels were significantly lower than those who had surgery. A re-analysis of the 453 patients followed between 1972 and 2011 was carried out and a 20-year survival analysis made of those diagnosed between 1972 and 1981 and those diagnosed between 1982 and 1991. The latter group had significantly worse relative mortality than the former group (P <0.001) but was significantly older at the time of diagnosis (56.94 +/- 14.83 vs 52.01 +/- 13.58, P <0.001). The serum calcium and serum PTH levels were not significantly different between these two groups. Crown Copyright (C) 2015 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:121 / 124
页数:4
相关论文
共 50 条
  • [31] Primary hyperparathyroidism
    Silva, Barbara C.
    Cusano, Natalie E.
    Bilezikian, John P.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 32 (05) : 593 - 607
  • [32] Primary hyperparathyroidism
    Rodgers, Steven E.
    Lew, John I.
    Solorzano, Carmen C.
    CURRENT OPINION IN ONCOLOGY, 2008, 20 (01) : 52 - 58
  • [33] Primary hyperparathyroidism
    Bilezikian, John P.
    Cusano, Natalie E.
    Khan, Aliya A.
    Liu, Jian-Min
    Marcocci, Claudio
    Bandeira, Francisco
    NATURE REVIEWS DISEASE PRIMERS, 2016, 2 : 1 - 16
  • [34] Parathyroid adenoma associated with thymoma in a female adult with primary hyperparathyroidism
    Maria, Verroiotou
    Saad, Al Mogrampi
    Ioannis, Fardellas
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2013, 4 (01): : 105 - 107
  • [35] Primary Hyperparathyroidism
    Marcocci, Claudio
    Cetani, Filomena
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (25) : 2389 - 2397
  • [36] Primary hyperparathyroidism
    Maruani, G.
    Corniere, N.
    Nicolet, L.
    Baron, S.
    Courbebaisse, M.
    Renaud, S.
    Houillier, P.
    REVUE DE MEDECINE INTERNE, 2013, 34 (10): : 605 - 613
  • [37] Primary hyperparathyroidism: diagnosis and management in 2017
    Syed, Hamid
    Khan, Aliya
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (06): : 438 - 441
  • [38] Primary hyperparathyroidism and vitamin D deficiency
    Velayoudom-Cephise, Fritz-Line
    Wemeau, Jean-Louis
    ANNALES D ENDOCRINOLOGIE, 2015, 76 (02) : 153 - 162
  • [39] The epidemiology of primary hyperparathyroidism in North America
    Melton, LJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : N12 - N17
  • [40] Cardiovascular Risk in Patients with Primary Hyperparathyroidism
    Tournis, Symeon
    Makris, Konstantinos
    Cavalier, Etienne
    Trovas, George
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (43) : 5628 - 5636